Use and continuity of weight-modifying medications among adults with diabetes and overweight/obesity: US population study.

ABSTRACT:

Objective

Trends in use and continuity of use of diabetes-specific and non-diabetes weight-reducing (WR), weight-inducing (WI), and weight-neutral (WN) medications were examined among US adults with diabetes and overweight/obesity.

Methods

Serial cross-sectional data from Medical Expenditure Panel Surveys (2010-2019) for adults (≥18 years) with diabetes and BMI ≥27 kg/m² (≥25 kg/m² for Asians) were analyzed.

Results

Among 7402 US adults with diabetes and overweight/obesity (mean age 60.0 years [SD 13], 50% female), 64.9% of participants used any WI medications, decreasing from 68.9% (95% CI: 64.3%-73.5%) in 2010 to 58.6% (95% CI: 54.7%-62.5%) in 2019. It was estimated that 13.5% used WR medications, increasing 3.31-fold, from 6.4% (95% CI: 4.1%-8

SUBMITTER: Galindo RJ 

PROVIDER: S-EPMC10840906 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature